您现在的位置是:straight talk device is not in valid format > Entertainment
【avenged sevenfold waking the fallen vinyl】Does Cosmo Pharmaceuticals N.V.’s (VTX:COPN) CEO Salary Compare Well With Others?
straight talk device is not in valid format2024-09-29 12:20:28【Entertainment】8人已围观
简介Alessandro Della Chà became the CEO of Cosmo Pharmaceuticals N.V. (VTX:COPN) in 2014. This analysis avenged sevenfold waking the fallen vinyl
Alessandro Della Chà became the CEO of Cosmo Pharmaceuticals N.V. (
VTX:COPN
) in 2014. This avenged sevenfold waking the fallen vinylanalysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that, we will consider the growth in the business. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO.
Check out our latest analysis for Cosmo Pharmaceuticals
How Does Alessandro Della Chà’s Compensation Compare With Similar Sized Companies?
At the time of writing our data says that Cosmo Pharmaceuticals N.V. has a market cap of CHF1.3b, and is paying total annual CEO compensation of €1.7m. (This figure is for the year to 2017). While we always look at total compensation first, we note that the salary component is less, at €30k. When we examined a selection of companies with market caps ranging from €874m to €2.8b, we found the median CEO compensation was €1.5m.
That means Alessandro Della Chà receives fairly typical remuneration for the CEO of a company that size. While this data point isn’t particularly informative alone, it gains more meaning when considered with business performance.
You can see, below, how CEO compensation at Cosmo Pharmaceuticals has changed over time.
SWX:COPN CEO Compensation January 1st 19
Is Cosmo Pharmaceuticals N.V. Growing?
Over the last three years Cosmo Pharmaceuticals N.V. has shrunk its earnings per share by an average of 126% per year. In the last year, its revenue is up 5.3%.
Few shareholders would be pleased to read that earnings per share are lower over three years. The fairly low revenue growth fails to impress given that the earnings per share is down. It’s hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration.
Shareholders might be interested in
this
free
visualization of analyst forecasts.
.
Has Cosmo Pharmaceuticals N.V. Been A Good Investment?
With a three year total loss of 44%, Cosmo Pharmaceuticals N.V. would certainly have some dissatisfied shareholders. So shareholders would probably think the company shouldn’t be too generous with CEO compensation.
In Summary…
Alessandro Della Chà is paid around the same as most CEOs of similar size companies.
The company isn’t growing EPS, and shareholder returns have been disappointing. Suffice it to say, we don’t think the CEO is underpaid! If you think CEO compensation levels are interesting you will probably really like
this free visualization of insider trading at Cosmo Pharmaceuticals.
Story continues
Of course,
the past can be informative
so you might be interested in considering
this
analytical visualization
showing the company history of earnings and revenue
.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
很赞哦!(656)
相关文章
- FITB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 8, 2020 in the Class Action Filed on Behalf of Fifth Third Bancorp Limited Shareholders
- Customer Data Reveals Shift in Peak Online Shopping Hours
- Camber Energy, Inc. and Viking Energy Group, Inc. Amend Definitive Merger Agreement Relating to Their Planned Combination and Provide Update on Status of Merger
- Microsoft Is in Talks to Buy TikTok in U.S.
- Which Consumer Staples Stock Will Grow The Most By 2025?
- Were Hedge Funds Right About Automatic Data Processing (ADP)?
- Company News for Mar 10, 2020
- The Global Military Ground Robot Market is expected to grow by $ 42.08 bn during 2020-2024 progressing at a CAGR of 27% during the forecast period
- Natural Gas Price Fundamental Weekly Forecast – Heating Season Begins with Hedge Funds Holding Long Positions
- Natural Gas Price Fundamental Weekly Forecast – Heating Season Begins with Hedge Funds Holding Long Positions
热门文章
- AUD/USD Weekly Price Forecast – Australian Dollar Rallies Significantly For The Week
- U.S. telehealth companies brace for demand spike as coronavirus spread accelerates
- Equitrans Midstream Corporation (ETRN) Stock Moves -1.99%: What You Should Know
- Bill.com Holdings Inc (BILL) President and CEO Rene A. Lacerte Sold $1.2 million of Shares
站长推荐
AUD/USD Forecast: Bottomed At 0.6038, At Risk Of Losing The 0.6000 Level
Were Hedge Funds Right About Automatic Data Processing (ADP)?
Antibodies, Protein-based Vaccines, Anti-virals, and Cell-based Therapies to Lead the Development of COVID-19 Treatment Pipeline- Exclusive Report by Meticulous Research®
Snapchat Ousts Trump’s Account From Discover Section
Want to land one of today's record-low mortgage rates? Follow these 4 tips
Key Things To Consider Before Buying Canaccord Genuity Group Inc. (TSE:CF) For Its Dividend
Thermon Group Holdings, Inc. to Host Earnings Call
Newmont (NEM) in Focus: Stock Moves 6.2% Higher
友情链接
- UK to extend furlough scheme beyond Dec. as BOE pumps in 150bln pounds - The Sun
- UK to extend furlough scheme beyond Dec. as BOE pumps in 150bln pounds - The Sun
- Smithfield Foods Says That the Company and Its Team Members Want the Same Thing: To Protect Employee Health and Safety While Also Safeguarding America’s Food Supply
- Open enrollment 2021: You may be able to carry over unused FSA funds of up to $550
- If You Had Bought NWF Group (LON:NWF) Shares Three Years Ago You'd Have Earned 30% Returns
- Microsoft Is in Talks to Buy TikTok in U.S.
- StockBeat: Virus Derails Intu's Rescue Plan
- Chromadex Corp. to Host Earnings Call
- Margaux Resources Announces Collaboration with GoldSpot Discoveries and Spring Work Program on Cassiar Gold Project
- Ambu A/S: Interim report for Q2 2019/20 and for the period 1 October 2019 to 31 March 2020